Literature DB >> 19329669

Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium.

Emmanouil Tampakakis1, Anton Y Peleg, Eleftherios Mylonakis.   

Abstract

Candida albicans is an opportunistic human fungal pathogen that normally resides in the gastrointestinal tract and on the skin as a commensal but can cause life-threatening invasive disease. Salmonella enterica serovar Typhimurium is a gram-negative bacterial pathogen that causes a significant amount of gastrointestinal infection in humans. Both of these organisms are also pathogenic to the nematode Caenorhabditis elegans, causing a persistent gut infection leading to worm death. In the present study, we used a previously developed C. elegans polymicrobial infection model to assess the interactions between S. Typhimurium and C. albicans. We observed that when C. elegans is infected with C. albicans and serovar Typhimurium, C. albicans filamentation is inhibited. The inhibition of C. albicans filamentation by S. Typhimurium in C. elegans appeared to be mediated by a secretary molecule, since filter-sterilized bacterial supernatant was able to inhibit C. albicans filamentation. In vitro coculture assays under planktonic conditions showed that S. Typhimurium reduces the viability of C. albicans, with greater effects seen at 37 degrees C than at 30 degrees C. Interestingly, S. Typhimurium reduces the viability of both yeast and filamentous forms of C. albicans, but the killing appeared more rapid for the filamentous cells. The antagonistic interaction was also observed in a C. albicans biofilm environment. This study describes the interaction between two diverse human pathogens that reside within the gastrointestinal tract and shows that the prokaryote, S. Typhimurium, reduces the viability of the eukaryote, C. albicans. Identifying the molecular mechanisms of this interaction may provide important insights into microbial pathogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19329669      PMCID: PMC2681611          DOI: 10.1128/EC.00016-09

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  23 in total

Review 1.  Transcription factors in Candida albicans - environmental control of morphogenesis.

Authors:  J F Ernst
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Control of filament formation in Candida albicans by the transcriptional repressor TUP1.

Authors:  B R Braun; A D Johnson
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  Caenorhabditis elegans is a model host for Salmonella typhimurium.

Authors:  A Labrousse; S Chauvet; C Couillault; C L Kurz; J J Ewbank
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

Review 4.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

6.  Attributable mortality of nosocomial candidemia, revisited.

Authors:  Olafur Gudlaugsson; Shane Gillespie; Kathleen Lee; Jeff Vande Berg; Jianfang Hu; Shawn Messer; Loreen Herwaldt; Michael Pfaller; Daniel Diekema
Journal:  Clin Infect Dis       Date:  2003-10-08       Impact factor: 9.079

7.  Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.

Authors:  H Liu; J Köhler; G R Fink
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

Review 8.  Cell-to-cell signalling in Escherichia coli and Salmonella enterica.

Authors:  Brian M M Ahmer
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

9.  Pseudomonas-Candida interactions: an ecological role for virulence factors.

Authors:  Deborah A Hogan; Roberto Kolter
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

10.  Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.

Authors:  Anton Y Peleg; Emmanouil Tampakakis; Beth Burgwyn Fuchs; George M Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-15       Impact factor: 11.205

View more
  30 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 2.  Caenorhabditis elegans, a model organism for investigating immunity.

Authors:  Elizabeth K Marsh; Robin C May
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

3.  Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system.

Authors:  Younghoon Kim; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2011-04-15

Review 4.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

Review 5.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

Review 6.  Modulation of morphogenesis in Candida albicans by various small molecules.

Authors:  Julie Shareck; Pierre Belhumeur
Journal:  Eukaryot Cell       Date:  2011-06-03

Review 7.  Biofilm models of polymicrobial infection.

Authors:  Rebecca A Gabrilska; Kendra P Rumbaugh
Journal:  Future Microbiol       Date:  2015-11-23       Impact factor: 3.165

8.  Binary Interactions of Antagonistic Bacteria with Candida albicans Under Aerobic and Anaerobic Conditions.

Authors:  Eliska Benadé; Wendy Stone; Marnel Mouton; Ferdinand Postma; Jac Wilsenach; Alfred Botha
Journal:  Microb Ecol       Date:  2015-11-14       Impact factor: 4.552

9.  Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans.

Authors:  Melissa R Cruz; Carrie E Graham; Bryce C Gagliano; Michael C Lorenz; Danielle A Garsin
Journal:  Infect Immun       Date:  2012-10-31       Impact factor: 3.441

10.  Characterization of mucosal Candida albicans biofilms.

Authors:  Anna Dongari-Bagtzoglou; Helena Kashleva; Prabhat Dwivedi; Patricia Diaz; John Vasilakos
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.